top of page
Search
Kuria Therapeutics to Present at 2023 Ophthalmology Futures Retina Forum
- Kuria's Chief Executive Officer Dr. Keith Ward to discuss preclinical proof-of-concept data in dry AMD and Kuria's development plans...
Keith Ward
Sep 20, 2023
Kuria Therapeutics Achieves Preclinical Proof-of-Concept for Age-Related Macular Degeneration
- Expands development pipeline with planned Phase 2 clinical trial for dry AMD Kuria Therapeutics, a pharmaceutical company developing a...
Keith Ward
Sep 8, 2023
bottom of page